tiprankstipranks
Biomerica Inc (BMRA)
NASDAQ:BMRA
US Market

Biomerica (BMRA) Stock Price & Analysis

305 Followers

BMRA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.70 - $2.13
Previous Close$0.73
Volume35.16K
Average Volume (3M)57.35K
Market Cap
$12.28M
Enterprise Value$6.09M
Total Cash (Recent Filing)$7.13M
Total Debt (Recent Filing)$937.00K
Price to Earnings (P/E)-1.9
Beta0.38
Aug 29, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding16,821,646
10 Day Avg. Volume77,231
30 Day Avg. Volume57,346
Standard Deviation0.27
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)1.34
Price to Sales (P/S)11.08
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.11
Enterprise Value/Gross Profit13.65
Enterprise Value/Ebitda-1.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

19.92%9.32%9.29%61.47%
19.92% Insiders
9.29% Other Institutional Investors
61.47% Public Companies and
Individual Investors

BMRA FAQ

What was Biomerica Inc’s price range in the past 12 months?
Biomerica Inc lowest stock price was $0.70 and its highest was $2.13 in the past 12 months.
    What is Biomerica Inc’s market cap?
    Currently, no data Available
    When is Biomerica Inc’s upcoming earnings report date?
    Biomerica Inc’s upcoming earnings report date is Aug 29, 2024 which is in 127 days.
      How were Biomerica Inc’s earnings last quarter?
      Biomerica Inc released its earnings results on Apr 12, 2024. The company reported -$0.114 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.114.
        Is Biomerica Inc overvalued?
        According to Wall Street analysts Biomerica Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biomerica Inc pay dividends?
          Biomerica Inc does not currently pay dividends.
          What is Biomerica Inc’s EPS estimate?
          Biomerica Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Biomerica Inc have?
          Biomerica Inc has 16,821,646 shares outstanding.
            What happened to Biomerica Inc’s price movement after its last earnings report?
            Biomerica Inc reported an EPS of -$0.114 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.229%.
              Which hedge fund is a major shareholder of Biomerica Inc?
              Currently, no hedge funds are holding shares in BMRA
              ---

              Biomerica Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -56.54%
              12-Months-Change

              Fundamentals

              Return on Equity
              -92.06%
              Trailing 12-Months
              Asset Growth
              25.97%
              Trailing 12-Months

              Company Description

              Biomerica Inc

              Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Aptose Biosciences
              Cel-Sci
              Genprex
              Inovio Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis